...
首页> 外文期刊>Contemporary Clinical Dentistry >Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent (Novaron?) against streptococcus mutans
【24h】

Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent (Novaron?) against streptococcus mutans

机译:纳米银碱性无机抗菌剂(Novaron?)对变形链球菌的最低抑菌和最低杀菌浓度的评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective:We attempted to find the possibility of determining the minimum inhibitory concentration and minimum bactericidal concentration needed for nano-silver base inorganic anti-microbial agent (Novaron? AG 300, AG 1100) against Streptococcus mutans in vitro using broth dilution assay.Materials and Methods:An ampoule of freeze-dried S. mutans NCTC reference strain was revived, and the colony-forming units (CFU) were calculated. The MIC and MBC was determined by broth dilution assay using different concentrations of Novaron? AG 300 and Novaron? AG 1100 against 1 × 105 CFU/ml of S. mutans.Results:The MIC and MBC of Novaron? AG 300 and Novaron? AG 1100 against S. mutans were found to be 40 μg/ml.Conclusions:Novaron? has anti-bacterial effect against S. mutans. Further studies are needed to explore the applicability of these silver-supported anti- microbial agents in clinical dentistry.
机译:目的:我们试图通过肉汤稀释测定法来确定纳米银基无机抗微生物剂(Novaron?AG 300,AG 1100)在体外对变形链球菌所需要的最低抑菌浓度和最低杀菌浓度。方法:复方冷冻干燥变形链球菌NCTC参考菌株的安瓿瓶,计算菌落形成单位(CFU)。 MIC和MBC通过肉汤稀释法使用不同浓度的Novaron TM测定。 AG 300和Novaron? AG 1100对抗1×105 CFU / ml变形链球菌。结果:Novaron的MIC和MBC? AG 300和Novaron?发现针对变形链球菌的AG 1100为40μg/ ml。结论:Novaron?对变形链球菌具有抗菌作用。需要进一步的研究以探索这些银载抗菌剂在临床牙科中的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号